Full Text View
Tabular View
No Study Results Posted
Related Studies
Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease
This study has been completed.
Study NCT00267085   Information provided by M.D. Anderson Cancer Center
First Received: December 19, 2005   Last Updated: July 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Myeloid Leukemia
Minimal Residual Disease
Additional conditions recognized in this trial
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Neoplasm, Residual
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplastic Processes
Pathologic Processes
Sponsors listed in this trial
M.D. Anderson Cancer Center
BreakThrough Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services